DJIA 18,096.90 -106.47 -0.58%
NASDAQ 4,967.14 -12.76 -0.26%
S&P 500 2,098.53 -9.25 -0.44%
market minute promo

11.06 0.17 (1.56%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VNDA $11.06 1.56%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.86
Previous Close $10.89
Daily Range $10.57 - $11.19
52-Week Range $8.34 - $19.25
Market Cap $374.9M
P/E Ratio 19.80
Dividend (Yield) $0.00 (0.0%)
Volume 1,680,863
Average Daily Volume 760,351
Current FY EPS -$0.61

Sector

Healthcare

Industry

Drug Makers

Vanda Pharmaceuticals, Inc. (VNDA) Description

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders. Website: http://www.vandapharmaceuticals.com/

News & Commentary

5 of Last Week's Biggest Winners

These five stocks posted double-digit percentage gains.

Vanda Pharma Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in A

Vanda Pharma Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatits

Vanda Pharmaceuticals May Not Make Sales Expectations

JMP Feeling Mostly Good On 4 Drug, Healthcare Stocks

Health Care Sector Update for 02/19/2015: VNDA,EPRS,CSLT

Vanda Pharmaceuticals (VNDA) Q4 2014 Results - Earnings Call Webcast

Use Options For a Chance To Buy VNDA at a 44% Discount

Use Options For a Chance To Buy VNDA at a 44% Discount

Vanda Pharmaceuticals (VNDA) Weak On High Volume

Cellceutix Overvalued By 90-99%

Vanda Pharmaceuticals shares bought

See More VNDA News...

VNDA's Top Competitors

VNDA $11.06 (1.56%)
Current stock: VNDA
AMGN $159.19 (0.40%)
Current stock: AMGN
GILD $103.06 (0.26%)
Current stock: GILD
BIIB $414.13 (0.32%)
Current stock: BIIB